Cite Filings / TWST / 0001104659-26-052496
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Twist Bioscience Corp · Filed 2026-04-30 · Acc 0001104659-26-052496

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-05-07 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-04-30 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-04-30 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-04-29 4 Director sold 500 shares at $61.83 ($30,915)
  • 2026-04-27 144 Sale of Securities
  • 2026-04-27 4 President and COO sold 2,321 shares at $60.76 ($141,026)
  • 2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 9.2%
  2. 2026-08-14 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 4.21%
  3. 2026-02-17 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 8.80%
  4. 2025-11-14 SCHEDULE 13G · EdgePoint Investment Group Inc. 6.76%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…